Medicinal Products Reimbursement

Dáil Éireann Debate, Wednesday - 27 February 2019

Wednesday, 27 February 2019

Ceisteanna (121)

Bobby Aylward

Ceist:

121. Deputy Bobby Aylward asked the Minister for Health if a decision has been made on the reimbursement of the drug Fasenra (benralizumab) by the HSE drugs leadership group; when he expects it to be made available to patients; and if he will make a statement on the matter. [9861/19]

Freagraí scríofa

Minister for Health

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.